Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001235481 | SCV001408170 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2021-08-26 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 102 of the SGCA protein (p.Val102Ile). The valine residue is moderately conserved and there is a small physicochemical difference between valine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987804 | SCV004804370 | uncertain significance | not specified | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001235481 | SCV002087555 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2020-07-29 | no assertion criteria provided | clinical testing |